CytoMed Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	24	56	-	-	-
Enterprise Value	17	50	2	1	2
PE Ratio	-18.04	-18.04	-	-	-
PB Ratio	2.85	6.63	-	-	-
P/FCF Ratio	-20.78	-20.78	-	-	-
P/OCF Ratio	-21.13	-21.13	-	-	-
EV/EBITDA Ratio	-17.85	-17.85	-1.01	-0.47	-1.36
EV/EBIT Ratio	-16.18	-16.18	-0.88	-0.39	-1.15
EV/FCF Ratio	-18.40	-18.40	-1.41	-0.32	-1.92
Debt / Equity Ratio	0.04	0.04	7.19	1.26	6.26
Debt / EBITDA Ratio	-0.12	-0.12	-1.62	-2.03	-1.94
Debt / FCF Ratio	-0.12	-0.12	-2.25	-1.42	-2.72
Quick Ratio	14.08	14.08	0.60	1.12	0.54
Current Ratio	14.08	14.08	0.60	1.12	0.54
Interest Coverage	-79.58	-79.58	-24.00	-16.43	-17.34
Return on Equity (ROE)	-69.90%	-69.90%	-197.00%	-133.70%	-
Return on Assets (ROA)	-47.00%	-47.00%	-55.40%	-41.50%	-
Return on Capital (ROIC)	-15.71%	-15.71%	-51.52%	-20.56%	-49.24%
Earnings Yield	-13.20%	-5.54%	-	-	-
FCF Yield	-11.21%	-4.81%	-	-	-
Buyback Yield / Dilution	-53.29%	-34.30%	-14.14%	-17.59%	-
Total Shareholder Return	-53.29%	-34.30%	-14.14%	-17.59%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).